Michelle Worst Honored With 2025 HOPA Volunteer Award
March 10, 2025 | CME, HOPA2025, HemOnc, OncologyEducation, VolunteerAward
Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of the 2025 HOPA Volunteer Award. Michelle is being honored for her exceptional dedication through committee and task force contributions, as well as representing the Hematology/Oncology Pharmacy Association (HOPA) at external events. Her commitment to hematology/oncology and her efforts in advancing education and collaboration make her a true leader in the field.
Reflecting on this recognition, Michelle shared, “My work in hematology/oncology is deeply personal, and I am passionate about advancing education, fostering collaboration, and ensuring we continue to elevate the standard of care for patients. Through my involvement in HOPA—whether shaping conference content, mentoring colleagues, or strategizing for the organization’s future—I’ve been fortunate to work alongside inspiring professionals who share a common goal: making a meaningful impact in oncology. I look forward to continuing this journey, driving innovation, and supporting the next generation of leaders in our field.”
Michelle will be formally honored at the 2025 HOPA Annual Conference during the Annual Member Business Meeting on Thursday, April 10th, at 10:50 AM PST.
At Medscape, we are committed to being the thread that runs through healthcare, connecting professionals with trusted education and insights that drive meaningful change. Our collective voice is one of credibility, passion, and an unwavering dedication to oncology education. Michelle’s contributions exemplify the spirit of volunteerism that strengthens the oncology community, and we celebrate her dedication to improving patient care. As we honor her remarkable achievements, we also look forward to our continued engagement at HOPA 2025.
Medscape will extend its presence at the HOPA Conference with our symposium:
- Pharmacist Perspectives: Navigating BCMA-Directed Therapies in Multiple Myeloma on Friday, April 11 from 6:30 PM – 7:30 PM.
Join us as we celebrate Michelle’s accomplishments and continue to advance oncology education together. Congratulations, Michelle, on this well-earned recognition!
For more information on Hematology/ Oncology Education please contact: Jelena Spyropoulos
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...
ESMO Patient Centricity – Highlights from Steve Clark
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...
ESMO Patient Centricity Highlights from Dr. Whyte
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...
Closing The Gaps in Patient-Centricity in Cancer Care
Highlights from the Medscape Education full panel discussion during this year's #ESMO22.